FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2761604906> ?p ?o ?g. }

• W2761604906 endingPage "212" @default.
• W2761604906 startingPage "207" @default.
• W2761604906 abstract "Study of the mechanisms involved in cancer progression suggests that cyclooxygenase enzymes play an important role in the induction of inflammation, tumor formation, and metastasis of cancer cells. Thus, cyclooxygenase enzymes could be considered for cancer chemotherapy. Among these enzymes, cyclooxygenase 2 (COX-2) is associated with liver carcinogenesis. Various COX-2 inhibitors cause growth inhibition of human hepatocellular carcinoma cells, but many of them act in the COX-2 independent mechanism. Thus, the introduction of selective COX-2 inhibitors is necessary to achieve a clear result. The present study was aimed to determine the growth-inhibitory effects of new analogues of chalcone epoxide as selective COX-2 inhibitors on the human hepatocellular carcinoma (HepG2) cell line.Estimation of both cell growth and the amount of prostaglandin E2 (PGE2) production were used to study the effect of selective COX-2 inhibitors on the hepatocellular carcinoma cell. Cell growth determination has done by MTT assay in 24 h, 48 h and 72 h, and PGE2 production has estimated by using ELYSA kit in 48 h and 72 h.The results showed growth inhibition of the HepG2 cell line in a concentration and time-dependent manner, as well as a reduction in the formation of PGE2 as a product of COX-2 activity. Among the compounds those analogues with methoxy and hydrogen group showed more inhibitory effect than others.The current in-vitro study indicates that the observed significant growth-inhibitory effect of chalcone-epoxide analogues on the HepG2 cell line may involve COX-dependent mechanisms and the PGE2 pathway parallel to the effect of celecoxib. It can be said that these analogues might be efficient compounds in chemotherapy of COX-2 dependent carcinoma specially preventing and treatment of hepatocellular carcinomas." @default.
• W2761604906 created "2017-10-20" @default.
• W2761604906 creator A5004301430 @default.
• W2761604906 creator A5064216244 @default.
• W2761604906 creator A5075132123 @default.
• W2761604906 creator A5079899532 @default.
• W2761604906 date "2017-09-30" @default.
• W2761604906 modified "2023-09-26" @default.
• W2761604906 title "Evaluation of Cytotoxicity Effects of Chalcone Epoxide Analogues as a Selective COX-II Inhibitor in the Human Liver Carcinoma Cell Line" @default.
• W2761604906 cites W1552290465 @default.
• W2761604906 cites W1577008343 @default.
• W2761604906 cites W1764097776 @default.
• W2761604906 cites W180357471 @default.
• W2761604906 cites W1846811799 @default.
• W2761604906 cites W1876192519 @default.
• W2761604906 cites W1946182096 @default.
• W2761604906 cites W1967257081 @default.
• W2761604906 cites W1971529620 @default.
• W2761604906 cites W1981211047 @default.
• W2761604906 cites W1989151475 @default.
• W2761604906 cites W1997024757 @default.
• W2761604906 cites W1997216546 @default.
• W2761604906 cites W2007187686 @default.
• W2761604906 cites W2020205806 @default.
• W2761604906 cites W2023520601 @default.
• W2761604906 cites W2025048412 @default.
• W2761604906 cites W2025499369 @default.
• W2761604906 cites W2025819074 @default.
• W2761604906 cites W2035093034 @default.
• W2761604906 cites W2037887091 @default.
• W2761604906 cites W2038554369 @default.
• W2761604906 cites W2042207719 @default.
• W2761604906 cites W2054137985 @default.
• W2761604906 cites W2058118671 @default.
• W2761604906 cites W2073738021 @default.
• W2761604906 cites W2084834427 @default.
• W2761604906 cites W2090106927 @default.
• W2761604906 cites W2103614172 @default.
• W2761604906 cites W2112497917 @default.
• W2761604906 cites W2113408403 @default.
• W2761604906 cites W2118278569 @default.
• W2761604906 cites W2131161059 @default.
• W2761604906 cites W2136684700 @default.
• W2761604906 cites W2141879384 @default.
• W2761604906 cites W2142142352 @default.
• W2761604906 cites W2146498309 @default.
• W2761604906 cites W2148712834 @default.
• W2761604906 cites W2283774595 @default.
• W2761604906 cites W2315613727 @default.
• W2761604906 cites W2440508293 @default.
• W2761604906 doi "https://doi.org/10.3831/kpi.2017.20.024" @default.
• W2761604906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5633673" @default.
• W2761604906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30087797" @default.
• W2761604906 hasPublicationYear "2017" @default.
• W2761604906 type Work @default.
• W2761604906 sameAs 2761604906 @default.
• W2761604906 citedByCount "9" @default.
• W2761604906 countsByYear W27616049062019 @default.
• W2761604906 countsByYear W27616049062020 @default.
• W2761604906 countsByYear W27616049062021 @default.
• W2761604906 countsByYear W27616049062022 @default.
• W2761604906 countsByYear W27616049062023 @default.
• W2761604906 crossrefType "journal-article" @default.
• W2761604906 hasAuthorship W2761604906A5004301430 @default.
• W2761604906 hasAuthorship W2761604906A5064216244 @default.
• W2761604906 hasAuthorship W2761604906A5075132123 @default.
• W2761604906 hasAuthorship W2761604906A5079899532 @default.
• W2761604906 hasBestOaLocation W27616049061 @default.
• W2761604906 hasConcept C104317684 @default.
• W2761604906 hasConcept C109316439 @default.
• W2761604906 hasConcept C134018914 @default.
• W2761604906 hasConcept C181199279 @default.
• W2761604906 hasConcept C185592680 @default.
• W2761604906 hasConcept C202751555 @default.
• W2761604906 hasConcept C2777956040 @default.
• W2761604906 hasConcept C2779689624 @default.
• W2761604906 hasConcept C2779707156 @default.
• W2761604906 hasConcept C2780764945 @default.
• W2761604906 hasConcept C2780783641 @default.
• W2761604906 hasConcept C502942594 @default.
• W2761604906 hasConcept C54355233 @default.
• W2761604906 hasConcept C55493867 @default.
• W2761604906 hasConcept C555283112 @default.
• W2761604906 hasConcept C62112901 @default.
• W2761604906 hasConcept C71240020 @default.
• W2761604906 hasConcept C81885089 @default.
• W2761604906 hasConcept C86803240 @default.
• W2761604906 hasConcept C98274493 @default.
• W2761604906 hasConceptScore W2761604906C104317684 @default.
• W2761604906 hasConceptScore W2761604906C109316439 @default.
• W2761604906 hasConceptScore W2761604906C134018914 @default.
• W2761604906 hasConceptScore W2761604906C181199279 @default.
• W2761604906 hasConceptScore W2761604906C185592680 @default.
• W2761604906 hasConceptScore W2761604906C202751555 @default.
• W2761604906 hasConceptScore W2761604906C2777956040 @default.
• W2761604906 hasConceptScore W2761604906C2779689624 @default.
• W2761604906 hasConceptScore W2761604906C2779707156 @default.
• W2761604906 hasConceptScore W2761604906C2780764945 @default.

• next